Validation of Treating to Non-Fasting Lipid Targets in Comparison to Fasting Lipid Targets

Validation of Treating to Non-Fasting Lipid Targets in Comparison to Fasting Lipid Targets - NoFastLipidStudy

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON41824

Enrollment

352

Registered

2015-03-31

Start date

2015-10-05

Completion date

Unknown

Last updated

2024-06-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

hypercholesterolemia Hyperlipidemia

Interventions

None listed

Eligibility

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: Male and female patients, aged 18 years or older, from the outpatient department of Cardiology and Internal Medicine receiving lipid lowering therapy as secondary cardiovascular prevention are suitable for inclusion. Lipid lowering therapy is defined as the use of statins, fibrates, ezetimibe or nicotinic acid or a combination of these.

Exclusion criteria

Exclusion criteria: None

Design outcomes

Primary

Measure	Time frame
-The number of patients that reach the set treatment target of LDL-C 2.5mmol/l.	—

Secondary

Measure	Time frame
The number of patients that reach the set treatment target of apo B	—

Countries

Netherlands

Outcome results